About Arivale
Arivale is a company based in Seattle (United States) founded in 2014. Arivale has raised $49.6 million across 2 funding rounds from investors including Arch Venture Partners, Polaris Partners and Maveron. Arivale operates in a competitive market with competitors including Helix, Counsyl, InformedDNA, Digbi Health and MyOme, among others.
- Headquarter Seattle, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Arivale Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$49.6 M (USD)
in 2 rounds
-
Latest Funding Round
$13.6 M (USD), Series C
Jun 13, 2017
-
Investors
Arch Venture Partners
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Arivale
Arivale has successfully raised a total of $49.6M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $13.6 million completed in June 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Arivale
Arivale has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Arch Venture Partners, Polaris Partners and Maveron.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
US focused venture capital firm
|
Locked | Locked | Locked | |
|
Venture capital firm focused on life science companies
|
Locked | Locked | Locked | |
|
Venture capital investments in consumer businesses, emphasizing technology and human behavior.
|
Locked | Locked | Locked |
Investor details for Arivale
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Arivale
Investment portfolio details for Arivale
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Arivale
Detailed financials for Arivale
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Arivale Comparisons
Peer comparison for Arivale
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Arivale
Arivale operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Counsyl, InformedDNA, Digbi Health and MyOme, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomic database for clinical research is provided.
|
|
| Locked | Locked | Locked |
DNA mapping for pre-pregnancy genetic testing, DNA and cancer screening
|
|
| Locked | Locked | Locked |
Network of genetics experts provided to assist patients and providers.
|
|
| Locked | Locked | Locked |
Personalized healthcare is delivered through DNA and gut biome testing.
|
|
| Locked | Locked | Locked |
Provider of a platform for gene analysis to determine genetic diseases and drug response
|
Detailed competitors of Arivale
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Arivale
Complete news archive for Arivale
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Arivale
Arivale was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Arivale is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Arivale is a funded company, having raised a total of $49.6M across 2 funding rounds to date.
Arivale was established in 2014 in Seattle, United States, within the bioscience sector. Testing of consumers genomes, blood, saliva, gut microbiomes, and lifestyles is conducted through direct-to-consumer services. Data from these analyses is processed to deliver tailored fitness and nutritional guidance. Operations focus on integrating genetic, clinical, and environmental factors for individualized health insights, with biotech pioneer Lee Hood among the founders.
Arivale's top competitors include Helix, Digbi Health and InformedDNA.
Arivale has 3 investors. Key investors include Arch Venture Partners, Polaris Partners, and Maveron.